Showing results (1121-1130 of 2,737) with videos related to
Sort By:
Pageof 274
Pharmacogenomics|December 17, 2008
Correlation between MDR1 methylation status in the promoter region and MDR1 genetic polymorphism in 194 healthy Chinese Han subjectsZhi-Ping Jiang, Ping Xu, Rong-Rong Liu, et al.Pharmacogenomics|December 24, 2008
Pharmacogenetics of debrisoquine and its use as a marker for CYP2D6 hydroxylation capacityAdrián Llerena, Pedro Dorado, Eva M Peñas-LledóPharmacogenomics|December 24, 2008
Glutathione S-transferase T1- and M1-null genotypes and coronary artery disease risk in patients with Type 2 diabetes mellitusSamantha Manfredi, Debora Calvi, Martina del Fiandra, et al.Pharmacogenomics|December 24, 2008
A Bayesian approach to gene-gene and gene-environment interactions in chronic fatigue syndromeEugene Lin, Sen-Yen HsuPharmacogenomics|December 24, 2008
Pharmacogenomics of gemcitabine in non-small-cell lung cancer and other solid tumorsRomano Danesi, Giuseppe Altavilla, Elisa Giovannetti, et al.Pharmacogenomics|December 24, 2008
Fit-for-purpose pharmacogenomic biomarkers in drug development: a project team case study with 'what-ifs'Linda C Surh, Lawrence J Lesko, Stuart Hobbs, et al.Pharmacogenomics|November 6, 2007
Impact of population admixture on the distribution of the CYP3A5*3 polymorphismGuilherme Suarez-Kurtz, Jamila A Perini, Luciana Bastos-Rodrigues, et al.Pharmacogenomics|November 6, 2007
Dopamine transporter polymorphisms and risperidone response in Chinese schizophrenia patients: an association studyAiping Zhang, Qinghe Xing, Lei Wang, et al.Pharmacogenomics|November 6, 2007
Polymorphisms in the mu-opioid receptor gene (OPRM1) and the implications for alcohol dependence in humansCarmen S van der Zwaluw, Esther van den Wildenberg, Reinout W Wiers, et al.Pharmacogenomics|November 6, 2007
Pyrosequencing for discovery and analysis of DNA sequence variationsMostafa Ronaghi, Shadi Shokralla, Baback GharizadehPageof 274